Dyne Therapeutics Inc. (DYN) NASDAQ
$11.52 -0.06 (-0.52%)
Market Cap: $649.02M
As of 03/31/23 04:00 PM EDT. Market closed.
Dyne Therapeutics Inc. (DYN)
NASDAQ
$11.52
-0.06 (-0.52%)
Market Cap: $649.02M
As of 03/31/23 04:00 PM EDT. Market closed.
Dyne Therapeutics, Inc. operates as a biotechnology company. The Company focuses on transforming the lives of people with serious diseases by developing muscle-targeted therapies. Dyne Therapeutics offers its services in the United ... read more
Dyne Therapeutics, Inc. operates as a biotechnology company. The Company focuses on transforming the lives of people with serious diseases by developing muscle-targeted therapies. Dyne Therapeutics offers its services in the United States. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$950,000
CEO Compensation (Total)
$6.94M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
93
CEO Compensation (Base)
$950,000
CEO Compensation (Total)
$6.94M
URL
Address
.
PRICE CHART FOR DYNE THERAPEUTICS INC
From:
To:
NEWS
KEY STATS
Open
$11.64
Previous Close
$11.58
Days Range
$11.21 - $11.75
52 week range
$4.30 - $15.63
Volume
401,428
Avg. Volume (30 days)
378,547
Market Cap
$649.02M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
56,338,214
Open
$11.64
Previous Close
$11.58
Days Range
$11.21 - $11.75
52 week range
$4.30 - $15.63
Volume
401,428
Avg. Volume (30 days)
378,547
Market Cap
$649.02M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
56,338,214
Open in: 
Open in:
INSIDER TRANSACTIONS FOR DYNE THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Scalzo Richard William | See Remarks | Mar 14, 2023 | Sale | $13.33 | 1,311 | 17,476 | 54,872 | Mar 15, 2023, 05:51 PM |
| McNeill Jonathan | See Remarks | Mar 14, 2023 | Sale | $13.33 | 1,209 | 16,116 | 65,391 | Mar 15, 2023, 05:50 PM |
| McNeill Jonathan | See Remarks | Mar 13, 2023 | Sale | $13.00 | 1,000 | 13,000 | 66,600 | Mar 15, 2023, 05:50 PM |
| HIGH SUSANNA GATTI | Chief Operating Officer | Mar 14, 2023 | Sale | $13.33 | 1,559 | 20,781 | 110,476 | Mar 15, 2023, 05:50 PM |
| Farwell Wildon | Chief Medical Officer | Mar 14, 2023 | Sale | $13.33 | 7,441 | 99,189 | 92,655 | Mar 15, 2023, 05:49 PM |
| Brumm Joshua T | See Remarks | Mar 14, 2023 | Sale | $13.33 | 7,318 | 97,549 | 322,483 | Mar 15, 2023, 05:49 PM |
| Beskrovnaya Oxana | Chief Scientific Officer | Mar 14, 2023 | Sale | $13.33 | 1,416 | 18,875 | 88,729 | Mar 15, 2023, 05:48 PM |
| McNeill Jonathan | See Remarks | Jan 18, 2023 | Option Exercise | $0.73 | 10,000 | 7,300 | 77,600 | Jan 23, 2023, 08:27 AM |
| McNeill Jonathan | See Remarks | Jan 18, 2023 | Sale | $14.03 | 10,000 | 140,300 | 67,600 | Jan 23, 2023, 08:27 AM |
| McNeill Jonathan | See Remarks | Jan 09, 2023 | Sale | $11.57 | 30,150 | 348,835 | 67,600 | Jan 11, 2023, 04:56 PM |
| Rhodes Jason P | Director | Dec 12, 2022 | Buy | $10.70 | 934,581 | 10,000,017 | 934,581 | Dec 14, 2022, 04:56 PM |
| Atlas Venture Opportunity Fund II, L.P. | 10% Owner | Dec 12, 2022 | Buy | $10.70 | 934,581 | 10,000,017 | 934,581 | Dec 14, 2022, 04:55 PM |
| Scalzo Richard William | See Remarks | Dec 12, 2022 | Sale | $10.87 | 312 | 3,391 | 56,183 | Dec 13, 2022, 05:06 PM |
| McNeill Jonathan | See Remarks | Dec 12, 2022 | Sale | $10.87 | 472 | 5,131 | 97,750 | Dec 13, 2022, 05:05 PM |
| HIGH SUSANNA GATTI | Chief Operating Officer | Dec 12, 2022 | Sale | $10.87 | 751 | 8,163 | 112,035 | Dec 13, 2022, 05:05 PM |
| Farwell Wildon | Chief Medical Officer | Dec 12, 2022 | Sale | $10.87 | 628 | 6,826 | 100,096 | Dec 13, 2022, 05:04 PM |
| Brumm Joshua T | See Remarks | Dec 12, 2022 | Sale | $10.87 | 3,322 | 36,110 | 329,801 | Dec 13, 2022, 05:04 PM |
| Beskrovnaya Oxana | Chief Scientific Officer | Dec 12, 2022 | Sale | $10.87 | 680 | 7,392 | 90,145 | Dec 13, 2022, 05:03 PM |
| Brumm Joshua T | See Remarks | Oct 10, 2022 | Option Exercise | $1.03 | 195,800 | 201,674 | 400,423 | Oct 11, 2022, 09:00 AM |
| Brumm Joshua T | See Remarks | Oct 07, 2022 | Option Exercise | $1.03 | 14,200 | 14,626 | 218,823 | Oct 11, 2022, 09:00 AM |
| Brumm Joshua T | See Remarks | Oct 07, 2022 | Sale | $13.37 | 14,200 | 189,854 | 204,623 | Oct 11, 2022, 09:00 AM |
| Brumm Joshua T | See Remarks | Oct 10, 2022 | Sale | $12.46 | 195,800 | 2,439,668 | 204,623 | Oct 11, 2022, 09:00 AM |
| Scalzo Richard William | See Remarks | Sep 20, 2022 | Option Exercise | $13.70 | 840 | 11,508 | 25,495 | Sep 21, 2022, 04:09 PM |
| McNeill Jonathan | See Remarks | Sep 20, 2022 | Option Exercise | $13.70 | 1,246 | 17,070 | 58,222 | Sep 21, 2022, 04:08 PM |
| HIGH SUSANNA GATTI | Chief Operating Officer | Sep 20, 2022 | Option Exercise | $13.70 | 2,629 | 36,017 | 68,786 | Sep 21, 2022, 04:08 PM |
| Brumm Joshua T | See Remarks | Sep 20, 2022 | Option Exercise | $13.70 | 11,836 | 162,153 | 204,623 | Sep 21, 2022, 04:07 PM |
| Beskrovnaya Oxana | Chief Scientific Officer | Sep 20, 2022 | Option Exercise | $13.70 | 1,413 | 19,358 | 50,825 | Sep 21, 2022, 04:07 PM |
| Scalzo Richard William | See Remarks | Sep 15, 2022 | Option Exercise | $14.05 | 326 | 4,580 | 26,335 | Sep 15, 2022, 05:30 PM |
| Farwell Wildon | Chief Medical Officer | Sep 15, 2022 | Option Exercise | $14.05 | 658 | 9,245 | 64,724 | Sep 15, 2022, 05:28 PM |
| McNeill Jonathan | See Remarks | Sep 15, 2022 | Option Exercise | $14.05 | 494 | 6,941 | 59,468 | Sep 15, 2022, 05:27 PM |
| HIGH SUSANNA GATTI | Chief Operating Officer | Sep 15, 2022 | Option Exercise | $14.05 | 786 | 11,043 | 71,415 | Sep 15, 2022, 05:26 PM |
| Brumm Joshua T | See Remarks | Sep 15, 2022 | Option Exercise | $14.05 | 3,480 | 48,894 | 216,459 | Sep 15, 2022, 05:25 PM |
| Beskrovnaya Oxana | Chief Scientific Officer | Sep 15, 2022 | Option Exercise | $14.05 | 712 | 10,004 | 52,238 | Sep 15, 2022, 05:24 PM |
| Brumm Joshua T | See Remarks | Jul 06, 2022 | Option Exercise | $8.24 | 10,963 | 90,335 | 219,939 | Jul 06, 2022, 06:18 PM |
| Scalzo Richard William | See Remarks | Jun 14, 2022 | Option Exercise | $4.95 | 333 | 1,648 | 26,661 | Jun 15, 2022, 08:05 PM |
| McNeill Jonathan | See Remarks | Jun 14, 2022 | Option Exercise | $4.95 | 504 | 2,495 | 59,962 | Jun 15, 2022, 08:04 PM |
| HIGH SUSANNA GATTI | Chief Operating Officer | Jun 14, 2022 | Option Exercise | $4.95 | 802 | 3,970 | 72,201 | Jun 15, 2022, 08:03 PM |
| Farwell Wildon | Chief Medical Officer | Jun 14, 2022 | Option Exercise | $4.95 | 668 | 3,307 | 65,382 | Jun 15, 2022, 08:03 PM |
| Brumm Joshua T | See Remarks | Jun 14, 2022 | Option Exercise | $4.95 | 3,540 | 17,523 | 206,784 | Jun 15, 2022, 08:02 PM |
| Beskrovnaya Oxana | Chief Scientific Officer | Jun 14, 2022 | Option Exercise | $4.95 | 726 | 3,594 | 52,950 | Jun 15, 2022, 08:02 PM |
| Scalzo Richard William | See Remarks | Mar 11, 2022 | Sale | $8.73 | 308 | 2,689 | 26,994 | Mar 14, 2022, 05:09 PM |
| McNeill Jonathan | See Remarks | Mar 11, 2022 | Sale | $8.73 | 481 | 4,199 | 60,466 | Mar 14, 2022, 05:09 PM |
| HIGH SUSANNA GATTI | Chief Operating Officer | Mar 11, 2022 | Sale | $8.73 | 765 | 6,678 | 73,003 | Mar 14, 2022, 05:08 PM |
| Farwell Wildon | Chief Medical Officer | Mar 11, 2022 | Sale | $8.73 | 640 | 5,587 | 66,050 | Mar 14, 2022, 05:08 PM |
| Brumm Joshua T | See Remarks | Mar 11, 2022 | Sale | $8.73 | 3,384 | 29,542 | 210,324 | Mar 14, 2022, 05:07 PM |
| Beskrovnaya Oxana | Chief Scientific Officer | Mar 11, 2022 | Sale | $8.73 | 693 | 6,050 | 53,676 | Mar 14, 2022, 05:06 PM |
| Farwell Wildon | Chief Medical Officer | Mar 02, 2022 | Sale | $8.56 | 5,617 | 48,082 | 66,690 | Mar 03, 2022, 07:22 PM |
| HIGH SUSANNA GATTI | Chief Operating Officer | Sep 23, 2021 | Sale | $17.22 | 2,451 | 42,206 | 33,453 | Sep 24, 2021, 10:50 AM |
| Scalzo Richard William | See Remarks | Sep 21, 2021 | Sale | $16.11 | 492 | 7,926 | 10,606 | Sep 22, 2021, 08:03 PM |
| Scalzo Richard William | See Remarks | Sep 20, 2021 | Sale | $15.61 | 367 | 5,729 | 11,098 | Sep 22, 2021, 08:03 PM |
| McNeill Jonathan | See Remarks | Sep 20, 2021 | Sale | $15.61 | 545 | 8,507 | 36,365 | Sep 22, 2021, 08:02 PM |
| McNeill Jonathan | See Remarks | Sep 21, 2021 | Sale | $16.11 | 729 | 11,744 | 35,636 | Sep 22, 2021, 08:02 PM |
| Brumm Joshua T | See Remarks | Sep 21, 2021 | Sale | $16.11 | 4,584 | 73,848 | 99,018 | Sep 22, 2021, 08:02 PM |
| Brumm Joshua T | See Remarks | Sep 20, 2021 | Sale | $15.61 | 3,425 | 53,464 | 103,602 | Sep 22, 2021, 08:02 PM |
| Beskrovnaya Oxana | Chief Scientific Officer | Sep 21, 2021 | Sale | $16.11 | 827 | 13,323 | 17,845 | Sep 22, 2021, 08:01 PM |
| Beskrovnaya Oxana | Chief Scientific Officer | Sep 20, 2021 | Sale | $15.61 | 617 | 9,631 | 18,672 | Sep 22, 2021, 08:01 PM |
| VV Manager II, LLC | 10% Owner | Sep 21, 2020 | Buy | $19.00 | 792,995 | 15,066,905 | 2,880,125 | Sep 23, 2020, 07:11 PM |
| VV Manager II, LLC | 10% Owner | Sep 21, 2020 | Buy | $19.00 | 22,005 | 418,095 | 79,921 | Sep 23, 2020, 07:11 PM |
| Logos Global Management LP | 10% Owner | Sep 21, 2020 | Buy | $19.00 | 700,000 | 13,300,000 | 1,504,392 | Sep 23, 2020, 07:09 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sep 21, 2020 | Buy | $19.00 | 660,000 | 12,540,000 | 2,805,045 | Sep 23, 2020, 06:55 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Scalzo Richard William | See Remarks | 03/14/2023 | 17,476 |
| McNeill Jonathan | See Remarks | 03/14/2023 | 16,116 |
| McNeill Jonathan | See Remarks | 03/13/2023 | 13,000 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 03/14/2023 | 20,781 |
| Farwell Wildon | Chief Medical Officer | 03/14/2023 | 99,189 |
| Brumm Joshua T | See Remarks | 03/14/2023 | 97,549 |
| Beskrovnaya Oxana | Chief Scientific Officer | 03/14/2023 | 18,875 |
| McNeill Jonathan | See Remarks | 01/18/2023 | 7,300 |
| McNeill Jonathan | See Remarks | 01/18/2023 | 140,300 |
| McNeill Jonathan | See Remarks | 01/09/2023 | 348,835 |
| Rhodes Jason P | Director | 12/12/2022 | 10,000,017 |
| Atlas Venture Opportunity Fund II, L.P. | 10% Owner | 12/12/2022 | 10,000,017 |
| Scalzo Richard William | See Remarks | 12/12/2022 | 3,391 |
| McNeill Jonathan | See Remarks | 12/12/2022 | 5,131 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 12/12/2022 | 8,163 |
| Farwell Wildon | Chief Medical Officer | 12/12/2022 | 6,826 |
| Brumm Joshua T | See Remarks | 12/12/2022 | 36,110 |
| Beskrovnaya Oxana | Chief Scientific Officer | 12/12/2022 | 7,392 |
| Brumm Joshua T | See Remarks | 10/10/2022 | 201,674 |
| Brumm Joshua T | See Remarks | 10/07/2022 | 14,626 |
| Brumm Joshua T | See Remarks | 10/07/2022 | 189,854 |
| Brumm Joshua T | See Remarks | 10/10/2022 | 2,439,668 |
| Scalzo Richard William | See Remarks | 09/20/2022 | 11,508 |
| McNeill Jonathan | See Remarks | 09/20/2022 | 17,070 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 09/20/2022 | 36,017 |
| Brumm Joshua T | See Remarks | 09/20/2022 | 162,153 |
| Beskrovnaya Oxana | Chief Scientific Officer | 09/20/2022 | 19,358 |
| Scalzo Richard William | See Remarks | 09/15/2022 | 4,580 |
| Farwell Wildon | Chief Medical Officer | 09/15/2022 | 9,245 |
| McNeill Jonathan | See Remarks | 09/15/2022 | 6,941 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 09/15/2022 | 11,043 |
| Brumm Joshua T | See Remarks | 09/15/2022 | 48,894 |
| Beskrovnaya Oxana | Chief Scientific Officer | 09/15/2022 | 10,004 |
| Brumm Joshua T | See Remarks | 07/06/2022 | 90,335 |
| Scalzo Richard William | See Remarks | 06/14/2022 | 1,648 |
| McNeill Jonathan | See Remarks | 06/14/2022 | 2,495 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 06/14/2022 | 3,970 |
| Farwell Wildon | Chief Medical Officer | 06/14/2022 | 3,307 |
| Brumm Joshua T | See Remarks | 06/14/2022 | 17,523 |
| Beskrovnaya Oxana | Chief Scientific Officer | 06/14/2022 | 3,594 |
| Scalzo Richard William | See Remarks | 03/11/2022 | 2,689 |
| McNeill Jonathan | See Remarks | 03/11/2022 | 4,199 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 03/11/2022 | 6,678 |
| Farwell Wildon | Chief Medical Officer | 03/11/2022 | 5,587 |
| Brumm Joshua T | See Remarks | 03/11/2022 | 29,542 |
| Beskrovnaya Oxana | Chief Scientific Officer | 03/11/2022 | 6,050 |
| Farwell Wildon | Chief Medical Officer | 03/02/2022 | 48,082 |
| HIGH SUSANNA GATTI | Chief Operating Officer | 09/23/2021 | 42,206 |
| Scalzo Richard William | See Remarks | 09/21/2021 | 7,926 |
| Scalzo Richard William | See Remarks | 09/20/2021 | 5,729 |
| McNeill Jonathan | See Remarks | 09/20/2021 | 8,507 |
| McNeill Jonathan | See Remarks | 09/21/2021 | 11,744 |
| Brumm Joshua T | See Remarks | 09/21/2021 | 73,848 |
| Brumm Joshua T | See Remarks | 09/20/2021 | 53,464 |
| Beskrovnaya Oxana | Chief Scientific Officer | 09/21/2021 | 13,323 |
| Beskrovnaya Oxana | Chief Scientific Officer | 09/20/2021 | 9,631 |
| VV Manager II, LLC | 10% Owner | 09/21/2020 | 15,066,905 |
| VV Manager II, LLC | 10% Owner | 09/21/2020 | 418,095 |
| Logos Global Management LP | 10% Owner | 09/21/2020 | 13,300,000 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | 09/21/2020 | 12,540,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN DYNE THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 2,618,618 | 0.00095% | 3.7% | Other |
| HHLR ADVISORS, LTD. | 939,648 | 0.23% | -6.04% | Other |
| CANDRIAM S.C.A. | 633,624 | 0.05% | 53.19% | Other |
| VIVO CAPITAL, LLC | 577,642 | 0.77% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 546,555 | 0.00089% | 2.42% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 400,000 | 0.01% | -11.11% | Other |
| UBS OCONNOR LLC | 208,191 | 0.07% | 17.96% | Value |
| RENAISSANCE TECHNOLOGIES LLC | 107,700 | 0.00171% | 2.67% | Other |
| TUDOR INVESTMENT CORP ET AL | 60,257 | 0.01% | 129.99% | Event Driven, Other |
| D. E. SHAW & CO., INC. | 13,246 | 0.00017% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR DYNE THERAPEUTICS INC
STOCK BUYBACKS FOR DYNE THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Period of Report: 12/31/2022
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2022
8.08%
1Q